arrow
P

Patricia Mulero

Universidad de Valladolid
H指数:26
被引数:3,210

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Recommendations for the critical reading of clinical trials on disease-modifying drugs for multiple sclerosis

关于治疗多发性硬化的疾病修正药物的临床试验的批判性阅读建议

2025-06-200
OAAI
Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
2025-03-010
PRE
Assessment of neuronal and glial serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease: the MULTIMOGAD study

评估髓磷脂少突胶质细胞糖蛋白抗体相关疾病中的神经元和神经胶质血清生物标志物: multimegad研究

2025-02-121
PRE
The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS
2019-10-1548
OAAI
Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study (vol 21, e14863, 2019)
2019-10-080
OA
Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study
2019-08-3080
OAAI
CLIPPERS and its mimics: evaluation of new criteria for the diagnosis of CLIPPERS
2019-05-0949
PREAI
Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis
2019-03-2644
OAAI
The value of oligoclonal bands in the multiple sclerosis diagnostic criteria
BRAIN
IF11.7
2018-02-1695
OAAI
Lesion topographies in multiple sclerosis diagnosis A reappraisal
2017-12-0531
OAAI
Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor

脊髓病变: 临床孤立综合征诊断的适度贡献者,但相关的预后因素

2017-03-1681
OAAI